Authors: Siu-Caldera, ML Rao, DS Astecker, N Weiskopf, A Vouros, P Konno, K Fujishima, T Takayama, H Peleg, S Reddy, GS

Citation: Ml. Siu-caldera et al., Tissue specific metabolism of 1 alpha,25-dihydroxy-20-epi-vitamin D-3 intonew metabolites with significant biological activity: Studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8), J CELL BIOC, 82(4), 2001, pp. 599-609

Authors: Schuessler, M Astecker, N Herzig, G Vorisek, G Schuster, I

Citation: M. Schuessler et al., Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D-3: CYP27 in epidermis completes the set of essential vitamin D-3-hydroxylases, STEROIDS, 66(3-5), 2001, pp. 399-408

Authors: Schuster, I Egger, H Astecker, N Herzig, G Schussler, M Vorisek, G

Citation: I. Schuster et al., Selective inhibitors of CYP24: mechanistic tools to explore vitamin D metabolism in human keratinocytes, STEROIDS, 66(3-5), 2001, pp. 451-462

Authors: Astecker, N Reddy, GS Herzig, G Vorisek, G Schuster, I

Citation: N. Astecker et al., 1 alpha 25-dihydroxy-3-epi-vitamin D-3 a physiological metabolite of 1 alpha,25-dihydroxyvitamin D-3: Its production and metabolism in primary human keratinocytes, MOL C ENDOC, 170(1-2), 2000, pp. 91-101

Authors: Reddy, GS Rao, DS Siu-Caldera, ML Astecker, N Weiskopf, A Vouros, P Sasso, GJ Manchand, PS Uskokovic, MR

Citation: Gs. Reddy et al., 1 alpha,25-dihydroxy-16-ene-23-yne-vitamin D-3 and 1 alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D-3: Analogs of 1 alpha,25-dihydroxyvitamin D-3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway, ARCH BIOCH, 383(2), 2000, pp. 197-205